Kestra Medical CEO Executes $304K Stock Sale, Company Posts Mixed Q3 Results
Kestra Medical Technologies CEO Brian Daniel Webster sold 15,000 common shares on March 17, 2026, generating roughly $304,123. The transaction was carried out under a Rule 10b5-1 trading plan adopted on September 29, 2025. The stock has fallen to $19.56, down 26% year-to-date, while the company reported fiscal third-quarter results that missed on E…